Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

BACKGROUND: Anticoagulation in patients with malignancy and atrial fibrillation is challenging because of enhanced risks for thrombosis and bleeding and the frequent need for invasive procedures. Data on direct oral antagonists in such patients are sparse. METHODS AND RESULTS: The ENGAGE AF‐TIMI 48...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: Fanola, Christina L., Ruff, Christian T., Murphy, Sabina A., Jin, James, Duggal, Anil, Babilonia, Noe A., Sritara, Piyamitr, Mercuri, Michele F., Kamphuisen, Pieter W., Antman, Elliott M., Braunwald, Eugene, Giugliano, Robert P.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201390/
https://ncbi.nlm.nih.gov/pubmed/30369307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.008987
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak